Full Name
Dr. Miven Donato
Job Title
RGCC Clinical Consultant & Trainer
Company
RGCC North America
Speaker Bio
Dr. Miven Donato brings a passion and wide-reaching educational background to RGCC’s North America based Clinical Support Team. Divinely guided to be a “doctor of the future” specializing in a whole person approach to care, coupled with his educational and clinical experience in Medical Technology (MT), Clinical Laboratory Science, Human Physical Performance, Physical Therapy (DPT), structural integrity and nutritional therapy, Chiropractic (DC), and specializing in dietary/nutritional therapy for cancer care as a Certified Gerson Practitioner and Trainer, makes him an exceptional asset to the RGCC NA team. His clinical background is rivaled only by his clinical experience working with patients in over 200 countries around the world.
Joining the RGCC practitioner community in 2018, Dr. Miven quickly became one of RGCC’s VIP practitioners interpreting several hundred tests along with creating personalized protocols with successful outcomes for his patients. His personal success is coupled with his enthusiasm for helping other colleagues learn the RGCC system to bring successful treatment outcomes for their patients too.
He joined the North America Clinical Advisory team in January 2022 and shares his extensive knowledge with new practitioners as a trainer in RGCC College and consultation support for the active practitioner community.
He is excited about the future of cancer care with RGCC as it continues to evolve in science and technology. He is eager to share his wisdom and proficiency with other practitioners wanting to bring RGCC testing into their practice.
Joining the RGCC practitioner community in 2018, Dr. Miven quickly became one of RGCC’s VIP practitioners interpreting several hundred tests along with creating personalized protocols with successful outcomes for his patients. His personal success is coupled with his enthusiasm for helping other colleagues learn the RGCC system to bring successful treatment outcomes for their patients too.
He joined the North America Clinical Advisory team in January 2022 and shares his extensive knowledge with new practitioners as a trainer in RGCC College and consultation support for the active practitioner community.
He is excited about the future of cancer care with RGCC as it continues to evolve in science and technology. He is eager to share his wisdom and proficiency with other practitioners wanting to bring RGCC testing into their practice.
Speaking At